Acarbose Cardiovascular Evaluation

Comparison of Medical Resources and Costs among Patients with Coronary Heart Disease and Impaired Glucose Tolerance in the Acarbose Cardiovascular Evaluation (ACE) Trial
Frauke Becker, Liam Mc Morrow, Jose Leal, Ruth L. Coleman, Hertzel C. Gerstein, Lars Rydén, Stefan Schröder, Alastair M. Gray, Rury R. Holman; for the ACE Study Group
Journal of Diabetes 2023;16:e13473. Published:Feb-2024. Epub:02-Nov-2023. PMID:37915263. doi:10.1111/1753-0407.13473

Risk prediction models for incident type 2 diabetes in Chinese people with intermediate hyperglycemia: a systematic literature review and external validation study
Shishi Xu, Ruth L. Coleman, Qin Wan, Yeqing Gu, Ge Meng, Kun Song, Zumin Shi, Qian Xie, Jaakko Tuomilehto, Rury R. Holman, Kaijun Niu and Nanwei Tong
Cardiovasc Diabetol. 2022;21:182. Published:13-Sep-2022. PMID:36100925. doi:10.1186/s12933-022-01622-5

Health utilities in Chinese patients with coronary heart disease and impaired glucose tolerance (ACE): A longitudinal analysis of a randomized, double-blind, placebo-controlled trial
José Leal, Fraucke Becker, Lee-Ling Lim, Rury R. Holman, Alastair M. Gray
J Diabetes 2022;14:455-464. Published:Jul-2022. PMID:35876124. doi:10.1111/1753-0407.13294

Predicting the Risk of Developing Type 2 diabetes in Chinese People who have Coronary Heart Disease and Impaired Glucose Tolerance
Shishi Xu, Charles A. B. Scott, Ruth L. Coleman, Jaakko Tuomilehto, Rury R. Holman
Journal of Diabetes 2021;13:817-826. Published:Oct-2021. Epub:04-Mar-2021. PMID:33665904. doi:10.1111/1753-0407.13175

Predicting Heart Failure Events in Patients with Coronary Heart Disease and Impaired Glucose Tolerance: Insights from the Acarbose Cardiovascular Evaluation (ACE) trial
Malgorzata Wamil, John JV McMurray, Charlie AB Scott, Ruth L Coleman, Yihong Sun, Eberhard Standl, Lars Rydèn, Rury R Holman
Diabetes Res Clin Pract. 2020;170:108488. Published:Dec-2020. Epub:06-Oct-2020. PMID:33035598. doi:10.1016/j.diabres.2020.108488

Impact of Acarbose on Incident Diabetes and Regression to Normoglycemia in People With Coronary Heart Disease and Impaired Glucose Tolerance: Insights From the ACE Trial
Hertzel C. Gerstein, Ruth L. Coleman, Charles A.B. Scott, Shishi Xu, Jaakko Tuomilehto, Lars Rydén, Rury R. Holman for the ACE Study Group
Diabetes Care 2020;43:2242-2247. Published:Sep-2020. Epub:08-Jul-2020. PMID:32641379. doi:10.2337/dc19-2046

Meta-analysis of the impact of alpha-glucosidase inhibitors on incident diabetes and cardiovascular outcomes
Ruth L. Coleman, Charles A. B. Scott, Zhihui Lang, M. Angelyn Bethel, Jaakko Tuomilehto and Rury R. Holman
Cardiovasc Diabetol 2019;18:135. Published:17-Oct-2019. PMID:31623625. doi:10.1186/s12933-019-0933-y

Effect of acarbose on cardiovascular events and new-onset diabetes in patients with coronary heart disease and impaired glucose tolerance
Yidong Wei, Wen Xu
Future Cardiology 2019;15:127-133. Published:Mar-2019. Epub:22-Feb-2019. PMID:30793928. doi:10.2217/fca-2018-0062

What does the ACE trial tell us? – Commentary
Rury R. Holman
Journal of Diabetes 2018;10:683-685. Published:Aug-2018. Epub:17-May-2018. PMID:29774661. doi:10.1111/1753-0407.12770

Baseline Characteristics and Temporal Differences in Acarbose Cardiovascular Evaluation (ACE) Trial Participants
Michael J. Theodorakis, Ruth L. Coleman, Huimei Feng, Juliana Chan, Jean-Louis Chiasson, Junbo Ge, Hertzel C. Gerstein, Yong Huo, Zhihui Lang, John J. McMurray, Lars Rydén, Stefan Schröder, Michal Tendera, Jaakko Tuomilehto, Wenying Yang, Dayi Hu, Changyu Pan and Rury R. Holman for the ACE Study Group
Am Heart J 2017;199:170-175. Published:May-2018. Epub:10-Sep-2017. PMID:29754657. doi:10.1016/j.ahj.2017.09.001

Effects of Acarbose on Cardiovascular and Diabetes Outcomes in Patients with Coronary Heart Disease and Impaired Glucose Tolerance: A Randomised Controlled Trial
Rury R Holman, Ruth L Coleman, Juliana C N Chan, Jean-Louis Chiasson, Huimei Feng, Junbo Ge, Hertzel C Gerstein, Richard Gray, Yong Huo, Zhihui Lang, John J McMurray, Lars Rydén, Stefan Schröder, Yihong Sun, Michael J Theodorakis, Michal Tendera, Lynne Tucker, Jaakko Tuomilehto, Yidong Wei, Wenying Yang, Duolao Wang, Dayi Hu, Changyu Pan for the ACE Study Group
Lancet Diabetes Endocrinol. 2017;5:877-86. Published:Nov-2017. Epub:13-Sep-2017. PMID:28917545. doi:10.1016/S2213-8587(17)30309-1
[Slides] [Slides #2]
Erratum in :
Lancet Diabetes Endocrinol. 2019;5:PE5, Print:May-2019, Epub:01-May-2019, doi:10.1016/S2213-8587(19)30063-4

Rationale for and design of the Acarbose Cardiovascular Evaluation (ACE) trial [Chinese republication]
Rury R Holman, Mary A Bethel, Juliana CN Chan, Jean-Louis Chiasson, Zoë Doran, Junbo Ge, Hertzel Gerstein, Yong Huo, John J McMurray, Lars Ryden, Winitha Liyanage, Stefan Schröder, Michal Tendera, Michael J Theodorakis, Jaakko Tuomilehto, Wenying Yang, Dayi Hu, Changyu Pan for the ACE Study Group
Int J Endocrinol Metab 2016;36:1-4. Published:May-2016. doi:10.3760/cma.j.issn.1673-4157.201.00.00

Rationale for and design of the Acarbose Cardiovascular Evaluation (ACE) trial [Chinese Abstract]
Hu Da Yi, Pan Chang Yu, Rury R. Holman.
Chinese Journal of Cardiology 2015;43:412. Published:24-May-2015. doi:10.3760/cma.j.issn.0253-3758.2015.05.008

Rationale for and design of the Acarbose Cardiovascular Evaluation (ACE) trial
Rury R Holman, Mary A Bethel, Juliana CN Chan, Jean-Louis Chiasson, Zoë Doran, Junbo Ge, Hertzel Gerstein, Yong Huo, John J McMurray, Lars Ryden, Winitha Liyanage, Stefan Schröder, Michal Tendera, Michael J Theodorakis, Jaakko Tuomilehto, Wenying Yang, Dayi Hu, Changyu Pan for the ACE Study Group
American Heart Journal 2014;168:23-29. Published:Jul-2014. Epub:05-Apr-2014. PMID:24952856. doi:10.1016/j.ahj.2014.03.021